573 related articles for article (PubMed ID: 10602411)
1. Standardized RT-PCR analysis of fusion gene transcripts from chromosome aberrations in acute leukemia for detection of minimal residual disease. Report of the BIOMED-1 Concerted Action: investigation of minimal residual disease in acute leukemia.
van Dongen JJ; Macintyre EA; Gabert JA; Delabesse E; Rossi V; Saglio G; Gottardi E; Rambaldi A; Dotti G; Griesinger F; Parreira A; Gameiro P; Diáz MG; Malec M; Langerak AW; San Miguel JF; Biondi A
Leukemia; 1999 Dec; 13(12):1901-28. PubMed ID: 10602411
[TBL] [Abstract][Full Text] [Related]
2. Primers and protocols for standardized detection of minimal residual disease in acute lymphoblastic leukemia using immunoglobulin and T cell receptor gene rearrangements and TAL1 deletions as PCR targets: report of the BIOMED-1 CONCERTED ACTION: investigation of minimal residual disease in acute leukemia.
Pongers-Willemse MJ; Seriu T; Stolz F; d'Aniello E; Gameiro P; Pisa P; Gonzalez M; Bartram CR; Panzer-Grümayer ER; Biondi A; San Miguel JF; van Dongen JJ
Leukemia; 1999 Jan; 13(1):110-8. PubMed ID: 10049045
[TBL] [Abstract][Full Text] [Related]
3. Fusion gene transcripts and Ig/TCR gene rearrangements are complementary but infrequent targets for PCR-based detection of minimal residual disease in acute myeloid leukemia.
Boeckx N; Willemse MJ; Szczepanski T; van der Velden VH; Langerak AW; Vandekerckhove P; van Dongen JJ
Leukemia; 2002 Mar; 16(3):368-75. PubMed ID: 11896540
[TBL] [Abstract][Full Text] [Related]
4. [Detection of BCR/ABL, MLL/AF4 and TEL/AML1 hybrid genes and monitoring of minimal residual disease in pediatric patients with acute lymphoblastic leukemia].
Trka J; Zuna J; Haskovec C; Brabencová A; Kalinová M; Muzíková K; Paukertová R; Hrusák O; Zemanová Z; Michalová K; Starý J
Cas Lek Cesk; 1999 Jan; 138(1):12-7. PubMed ID: 10953429
[TBL] [Abstract][Full Text] [Related]
5. Standardization and quality control studies of 'real-time' quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia - a Europe Against Cancer program.
Gabert J; Beillard E; van der Velden VH; Bi W; Grimwade D; Pallisgaard N; Barbany G; Cazzaniga G; Cayuela JM; Cavé H; Pane F; Aerts JL; De Micheli D; Thirion X; Pradel V; González M; Viehmann S; Malec M; Saglio G; van Dongen JJ
Leukemia; 2003 Dec; 17(12):2318-57. PubMed ID: 14562125
[TBL] [Abstract][Full Text] [Related]
6. Simple multiplex RT-PCR for identifying common fusion transcripts in childhood acute leukemia.
Pakakasama S; Kajanachumpol S; Kanjanapongkul S; Sirachainan N; Meekaewkunchorn A; Ningsanond V; Hongeng S
Int J Lab Hematol; 2008 Aug; 30(4):286-91. PubMed ID: 18665825
[TBL] [Abstract][Full Text] [Related]
7. TEL-AML1 fusion RNA as a new target to detect minimal residual disease in pediatric B-cell precursor acute lymphoblastic leukemia.
Cayuela JM; Baruchel A; Orange C; Madani A; Auclerc MF; Daniel MT; Schaison G; Sigaux F
Blood; 1996 Jul; 88(1):302-8. PubMed ID: 8704188
[TBL] [Abstract][Full Text] [Related]
8. [Detection of 29 types of fusion gene in leukemia by multiplex RT-PCR].
Li ZG; Wu MY; Zhao W; Li B; Yang J; Zhu P; Hu YM
Zhonghua Xue Ye Xue Za Zhi; 2003 May; 24(5):256-8. PubMed ID: 12859878
[TBL] [Abstract][Full Text] [Related]
9. [Detection of common fusion transcript levels in untreated leukemia patients by real-time quantitative RT-PCR technique].
Qin YZ; Li JL; Zhu HH; Li LD; Chang Y; Le H; Ruan GR; Liu YR; Huang XJ; Chen SS
Zhonghua Xue Ye Xue Za Zhi; 2007 Jul; 28(7):433-7. PubMed ID: 18072623
[TBL] [Abstract][Full Text] [Related]
10. Rapid screening of leukemia fusion transcripts in acute leukemia by real-time PCR.
Osumi K; Fukui T; Kiyoi H; Kasai M; Kodera Y; Kudo K; Kato K; Matsuyama T; Naito K; Tanimoto M; Hirai H; Saito H; Ohno R; Naoe T
Leuk Lymphoma; 2002 Dec; 43(12):2291-9. PubMed ID: 12613515
[TBL] [Abstract][Full Text] [Related]
11. Detection of fusion genes at the protein level in leukemia patients via the flow cytometric immunobead assay.
Dekking E; van der Velden VH; Böttcher S; Brüggemann M; Sonneveld E; Koning-Goedheer A; Boeckx N; Lucio P; Sedek L; Szczepański T; Kalina T; Kovac M; Evans P; Hoogeveen PG; Flores-Montero J; Orfao A; Comans-Bitter WM; Staal FJ; van Dongen JJ;
Best Pract Res Clin Haematol; 2010 Sep; 23(3):333-45. PubMed ID: 21123134
[TBL] [Abstract][Full Text] [Related]
12. Slower molecular response to treatment predicts poor outcome in patients with TEL/AML1 positive acute lymphoblastic leukemia: prospective real-time quantitative reverse transcriptase-polymerase chain reaction study.
Madzo J; Zuna J; Muzíková K; Kalinová M; Krejcí O; Hrusák O; Otová B; Starý J; Trka J
Cancer; 2003 Jan; 97(1):105-13. PubMed ID: 12491511
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of common fusion transcripts in acute lymphoblastic leukemia: A report of 304 cases.
Chopra A; Soni S; Verma D; Kumar D; Dwivedi R; Vishwanathan A; Vishwakama G; Bakhshi S; Seth R; Gogia A; Kumar L; Kumar R
Asia Pac J Clin Oncol; 2015 Dec; 11(4):293-8. PubMed ID: 26264145
[TBL] [Abstract][Full Text] [Related]
14. [Real-time PCR array for simultaneous detection of 37 kinds of fusion genes in leukemia].
Liu HX; Zhu P; Zhang Y; Wang HX; DU JW; Liu J; Gu JY; Ou Y
Zhonghua Yi Xue Za Zhi; 2007 Feb; 87(8):526-32. PubMed ID: 17459201
[TBL] [Abstract][Full Text] [Related]
15. Detection of minimal residual disease in hematologic malignancies by real-time quantitative PCR: principles, approaches, and laboratory aspects.
van der Velden VH; Hochhaus A; Cazzaniga G; Szczepanski T; Gabert J; van Dongen JJ
Leukemia; 2003 Jun; 17(6):1013-34. PubMed ID: 12764363
[TBL] [Abstract][Full Text] [Related]
16. Diagnosis and monitoring of PML-RARA-positive acute promyelocytic leukemia by qualitative RT-PCR.
Rossi V; Levati L; Biondi A
Methods Mol Med; 2006; 125():115-26. PubMed ID: 16502581
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of minimal residual disease quantification by real-time reverse transcriptase polymerase chain reaction in patients with core binding factor leukemias.
Krauter J; Gorlich K; Ottmann O; Lubbert M; Dohner H; Heit W; Kanz L; Ganser A; Heil G
J Clin Oncol; 2003 Dec; 21(23):4413-22. PubMed ID: 14645432
[TBL] [Abstract][Full Text] [Related]
18. The TEL-AML1 real-time quantitative polymerase chain reaction (PCR) might replace the antigen receptor-based genomic PCR in clinical minimal residual disease studies in children with acute lymphoblastic leukaemia.
de Haas V; Breunis WB; Dee R; Verhagen OJ; Kroes W; van Wering ER; van Dongen JJ; van den Berg H; van der Schoot CE
Br J Haematol; 2002 Jan; 116(1):87-93. PubMed ID: 11841400
[TBL] [Abstract][Full Text] [Related]
19. Multiplex RT-PCR assay for the detection of major fusion transcripts in Taiwanese children with B-lineage acute lymphoblastic leukemia.
Liang DC; Shih LY; Yang CP; Hung IJ; Chen SH; Jaing TH; Liu HC; Chang WH
Med Pediatr Oncol; 2002 Jul; 39(1):12-7. PubMed ID: 12116073
[TBL] [Abstract][Full Text] [Related]
20. Monitoring of minimal residual disease (MRD) by real-time quantitative reverse transcription PCR (RQ-RT-PCR) in childhood acute myeloid leukemia with AML1/ETO rearrangement.
Viehmann S; Teigler-Schlegel A; Bruch J; Langebrake C; Reinhardt D; Harbott J
Leukemia; 2003 Jun; 17(6):1130-6. PubMed ID: 12764380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
